[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"financial-stress\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:financial-stress":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,41,99,112,140,167],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100053444","big-chicago-a-trial-of-basic-income-guarantee-for-young-people-living-with-hiv-100053444",false,"NCT07502365","BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV","Inclusion Criteria:\n\n* Living with HIV for 24 months or longer;\n* Ages 18-35;\n* English-speaking;\n* One or both of the following:\n\n  1. Experienced a gap in HIV provider care of 6 or greater months during the prior 12-month period;\n  2. Had an unsuppressed viral load at any point within the prior 12-month period (unsuppressed meaning a viral load of 200 copies\u002FmL or higher);\n* Household income at or below 250% of the Federal Poverty Level; and\n* Experiencing financial distress, as based on a financial well-being score of 1-4 (high financial distress).\n\nExclusion Criteria:\n\n* Unwilling\u002Funable to provide informed consent\n* Unable to confirm HIV status\n* Unable to conduct the study in English","ALL","18 Years","35 Years",{"count":19,"type":20},304,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships.\n\nThe main question it aims to answer is:\n\nCompared with the Treatment as Usual group, will participants in the BIG + Treatment as Usual group be more likely to improve care engagement and viral suppression?\n\nParticipants on the study will be:\n\n* Randomly assigned (like the flip of a coin) to participate in either BIG + Treatment as Usual or Treatment as Usual. Participants will have an equal chance of being placed in either group.\n* Complete 9 surveys over a 36 month period.\n* Complete a release of information so electronic medical record data can be accessed for the 18 months prior to treatment engagement and for 36 months from program enrollment.\n* Participants in the Treatment as Usual group will not receive any intervention.\n* HIV viral load testing will be confirmed at 3 timepoints (baseline, 12 months, and 18 months).\n* Participants in the BIG + Treatment as Usual group will receive $500 monthly income for 18 months.\n* Participants in the BIG + Treatment as Usual group will complete 3 social network surveys to assess how receiving BIG impacts their social networks.\n* A subset of participants in the BIG + Treatment as Usual group (30 participants) will complete 5 individual interviews over the course of receiving BIG and the 18 months after.",[26,27],"HIV","Financial Stress",[26,27],"NOT_YET_RECRUITING","2026-07-10",{"date":32,"type":33},"2026-07-13","ACTUAL",{"date":35,"type":20},"2026-07",{"date":37,"type":20},"2030-07",{"name":39,"class":40},"University of Chicago","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":50,"targetDuration":52,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":68,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":98},"100640521","neurofinance-human-stress-trial-during-financial-and-informational-volatility-100640521","NCT07622589","NeuroFinance Human Stress Trial During Financial and Informational Volatility","NeuroFinance Human Stress Trial During Financial and Informational Volatility (NFHST)","NFHST","Inclusion Criteria:\n\n* Adults age 18 years and older.\n* Ability to provide informed consent.\n* Willingness and ability to comply with study procedures and remote monitoring requirements.\n* Access to a compatible smartphone, tablet, or internet-connected device for decentralized study participation.\n* Willingness to utilize wearable physiologic monitoring technologies during the study period.\n* Participants with varying degrees of financial market exposure, occupational stress exposure, or digital media exposure are eligible.\n* Healthy volunteers and participants with self-reported stress-related symptoms may be enrolled.\n* Ability to read and understand English-language consent and study materials.\n\nExclusion Criteria:\n\n* Individuals unable or unwilling to provide informed consent.\n* Individuals unable to comply with remote monitoring procedures or wearable device usage requirements.\n* Active medical or psychiatric instability that, in the opinion of study investigators, may interfere with study participation or data integrity.\n* Current incarceration or institutionalization limiting voluntary participation.\n* Participation in another interventional clinical trial that may substantially interfere with physiologic monitoring outcomes.\n* Any condition that would significantly impair safe study participation as determined by the study investigators.",true,{"count":51,"type":20},2500,"24 Months","OBSERVATIONAL","The NeuroFinance Human Stress Trial (NFHST-2026-001) is a decentralized observational clinical study designed to evaluate how financial market volatility, economic uncertainty, digital media exposure, and information-driven stress environments affect human physiologic and behavioral health. Participants will undergo remote monitoring using wearable biosensors, cardiovascular telemetry devices, sleep tracking systems, heart rate variability monitoring, and behavioral analytics platforms. The study will use artificial intelligence and machine learning systems to analyze relationships between external financial and informational events and biologic stress responses, including autonomic nervous system activity, sleep disruption, cardiovascular strain, emotional resilience, and inflammatory signaling. The goal of the study is to develop predictive digital biomarkers and AI-assisted forecasting systems capable of identifying stress-related physiologic deterioration before clinical manifestation.",[56,57,58,59,60,61,62,63,64,27,65,66,67],"Psychological Stress","Anxiety","Emotional Stress","Autonomic Nervous System Dysfunction","Sleep Disturbance","Insomnia","Behavioral Health","Cognitive Fatigue","Occupational Stress","Burnout Syndrome","Heart Rate Variability","Neurobehavioral Manifestations",[69,70,71,72,73,74,66,75,76,77,78,79,80,81,82,83,84,85,86,87],"NeuroFinance","Financial Stress Medicine","Wearable Biosensors","Artificial Intelligence","Machine Learning","Digital Biomarkers","Sleep Monitoring","Behavioral Analytics","Cardiovascular Telemetry","Decentralized Clinical Trial","Emotional Resilience","Physiologic Stress","Market Volatility","Economic Uncertainty","Social Media Exposure","Cognitive Performance","Stress Forecasting","Precision Wellness","Remote Patient Monitoring","2026-05-27",{"date":90,"type":33},"2026-06-03",{"date":92,"type":20},"2026-07-15",{"date":94,"type":20},"2029-06-30",{"name":96,"class":97},"Truway Health, Inc.","INDUSTRY",1,{"id":100,"slug":4,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":101,"targetDuration":4,"studyType":21,"phases":102,"briefSummary":24,"conditions":103,"keywords":104,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":111,"locationsCount":4},"100631567",{"count":19,"type":20},[23],[26,27],[26,27],"2026-04-06",{"date":107,"type":33},"2026-04-13",{"date":109,"type":20},"2026-04",{"date":37,"type":20},{"name":39,"class":40},{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":49,"sex":15,"minAge":16,"maxAge":119,"enrollmentInfo":120,"targetDuration":4,"studyType":21,"phases":122,"briefSummary":123,"conditions":124,"keywords":126,"overallStatus":130,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":98},"100627069","oncology-legal-navigation-study-100627069","NCT07443839","Oncology Legal Navigation Study","Oncology Legal Navigation- Medical Legal Partnership","Inclusion Criteria:\n\n* receiving or have received services at the Markey Cancer Center, University of Kentucky\n* patient with cancer diagnosis\n* caregiver of patient with cancer diagnosis\n* 18 years or older\n* facing legal barriers to care\n\nExclusion Criteria:\n\n* Unable to provide consent","100 Years",{"count":121,"type":20},60,[23],"The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related quality of life (QOL) among patients\u002Fcaregivers.",[27,125],"Oncology Patients",[127,128,129],"Financial toxicity","Hardship","Cost conversations","RECRUITING","2026-03-03",{"date":133,"type":33},"2026-03-05",{"date":135,"type":33},"2025-03-24",{"date":137,"type":20},"2026-12-31",{"name":139,"class":40},"Jean Edward",{"id":141,"slug":142,"hasResults":11,"nctId":143,"briefTitle":144,"officialTitle":145,"acronym":4,"eligibilityCriteria":146,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":147,"enrollmentInfo":148,"targetDuration":4,"studyType":21,"phases":150,"briefSummary":151,"conditions":152,"keywords":156,"overallStatus":130,"whyStopped":4,"lastUpdateSubmitDate":157,"lastUpdatePostDateStruct":158,"startDateStruct":160,"completionDateStruct":162,"leadSponsor":164,"locationsCount":166},"100537855","pedirise-feasibility-100537855","NCT06283251","PediRISE Feasibility","Pilot Randomized Pediatric RISE (Resource Intervention to Support Equity) Feasibility Study","Inclusion Criteria\n\nCohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy\n\n1. Child diagnosed with de novo cancer\n2. Child has established care at a study site and initiated cancer directed therapy in the prior 2-months\n3. Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan\n4. Child is \\\u003C18 years at time of enrollment\n5. Parent\u002Fguardian screened positive for self-reported low-income (\\\u003C200% FPL)\n6. Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI\n7. Provider approval for permission to approach\n\nCohort 2: Poverty-exposed children with cancer undergoing HSCT\n\n1. Child undergoing allogeneic HSCT for treatment of cancer\n2. Child has established care at a study site and is between 30 days prior to start of planned conditioning through day +7 of HSCT at time of enrollment\n3. Child planned to receive follow-up care after discharge for HSCT at study site\n4. Child is \\\u003C18 years at the time of enrollment\n5. Parent\u002Fguardian screen positive for self-reported low-income (\\\u003C200% FPL)\n6. Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI\n7. Provider approval for permission to approach\n\nExclusion Criteria\n\nCohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy\n\n1. Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy\n2. Foreign national family receiving care as an Embassy-pay patient\n3. Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies\n4. Child or household member receiving SSI\n\nCohort 2: Poverty-exposed children with cancer undergoing HSCT\n\n1. Planned transfer of child to a non-DFCI, non-Columbia, or non UCSF facility for cancer-directed therapy\n2. Foreign national family receiving care as an Embassy-pay patient\n3. Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies\n4. Child previously received RISE intervention\n5. Child or household member receiving SSI","17 Years",{"count":149,"type":20},40,[23],"The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program.\n\nThe names of the study groups in this research study are:\n\n* PediRISE Program Group\n* Usual Care Group",[153,27,154,155],"Pediatric Cancer","Financial Hardship","Disparities",[153,27,154,155],"2026-02-09",{"date":159,"type":33},"2026-02-10",{"date":161,"type":33},"2024-05-15",{"date":163,"type":20},"2027-06-30",{"name":165,"class":40},"Dana-Farber Cancer Institute",4,{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":173,"eligibilityCriteria":174,"healthyVolunteers":49,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":175,"targetDuration":4,"studyType":21,"phases":177,"briefSummary":178,"conditions":179,"keywords":185,"overallStatus":130,"whyStopped":4,"lastUpdateSubmitDate":187,"lastUpdatePostDateStruct":188,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":98},"100609644","proactive-costs-of-care-study-100609644","NCT07217262","Proactive Costs of Care Study","An Open, Single-arm, Single-site Study to Evaluate the Proactive Costs of Care (PCOC) Intervention Delivered by a Trained Lay Educator to Test Feasibility With the Goal of Improving Self-efficacy Among Patients With Gynecologic Cancer on Active Therapy and Their Caregivers","PCOC","Inclusion Criteria for Patient Participants:\n\n* Individuals 18 years old or older are included.\n* Individuals diagnosed with gynecologic cancer\n* On active systemic therapy within 30 days of enrollment\n* Receiving treatment at Cedars-Sinai Medical Center\n* Can speak, read, and understand English\n\nInclusion Criteria for Caregiver Participants:\n\n\\- Caregivers to patients who satisfy the criteria above\n\nExclusion Criteria for Patient and Caregiver Participants:\n\n* Any patients whose records are flagged \"break the glass\" or \"research opt out.\"\n* Cannot speak, read, or understand English\n* Not willing to participate in the intervention or complete surveys",{"count":176,"type":20},36,[23],"The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this trial is to evaluate whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients who are starting a new treatment and their caregivers by looking at how many participants complete the intervention. The other questions the trial aims to answer are whether the intervention can:\n\n* Improve confidence in solving problems related to costs of care\n* Reduce distress related to finances\n\nParticipants will complete the Proactive Costs of Care intervention, which is an approximately 30-minute one-time session with a lay educator reviewing the Proactive Costs of Care Guide and Cost Tracker. The intervention can be completed in person, by video, and by phone. Participants will also complete two surveys- one to be completed before the intervention and one to be completed 3 months after the intervention.",[180,181,27,182,183,184],"Financial Burden","Financial Toxicity","Financial Navigation","Gynecologic Cancers","Caregiver Burnout",[182,181,186,180,183,184],"Financial Distress","2026-02-06",{"date":159,"type":33},{"date":190,"type":33},"2025-12-22",{"date":192,"type":20},"2027-04",{"name":194,"class":40},"Cedars-Sinai Medical Center"]